Last deal

$125M

Amount

Series B

Stage

13.06.2024

Date

3

all rounds

$168.34M

Total amount

date founded

Financing round

General

About Company
Santa Ana Bio designs precision biologics for autoimmune diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2021

Number of employees

Last funding type

Series B

IPO status

Private

Description

Founded in 2021 and based in Alameda, California, Santa Ana Bio is a biotechnology company that utilizes deep cell profiling technologies to create targeted biologics in the field of autoimmune diseases. With a focus on precision medicine, the company aims to develop therapies that specifically address the underlying causes of these conditions. By leveraging advanced profiling techniques, Santa Ana Bio is able to gain a deep understanding of cellular mechanisms and design biologics that can effectively modulate the immune system. Headquartered in the heart of California's biotech hub, the company is well-positioned to drive innovation in the autoimmune space and potentially revolutionize treatment options for patients.
Contacts

Social url

Similar Companies
1000
Eligo Bioscience

Eligo Bioscience

Eligo Bioscience develops antibiotics to treat microbiome precision and bacteria-associated diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Paris, France

total rounds

9

total raised

$64.79M
Locus Biosciences

Locus Biosciences

Locus Biosciences develops bacteriophage-based products to remove pathogenic bacteria and treat diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Morrisville, NC, USA

total rounds

11

total raised

$152.59M
Immudicon

Immudicon

Immudicon creates complement-based biologics that target and localize immune cells to tumors.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

total rounds

1
RadBio

RadBio

RADBiotech (RADBIO) is a biotech company that develops novel biological drugs and biomarkers for complex chronic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Biopharma, Health Care

Location

New Castle, DE 19720, USA

Financials

Funding Rounds
3
3

Number of Funding Rounds

$168.34M

Money Raised

Their latest funding was raised on 13.06.2024. Their latest investor Andreessen Horowitz. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
13.06.2024
4
$125M
28.02.2023
2
$35.31M
01.06.2021
$8.02M
GV

GV

GV is a venture capital firm that provides funding to innovative startups in various fields.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Mountain View, CA, USA

count Of Investments

820

count Of Exists

169
Co-Investors
Investors
6
1

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
Andreessen Horowitz

Andreessen Horowitz

Andreessen Horowitz (a16z) is a venture capital firm that invests in technology companies at various stages of development.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Software, Venture Capital

Location

Menlo Park, CA, USA

count Of Investments

1188

count Of Exists

153
Vineeta Agarwala

Vineeta Agarwala

Vineeta Agarwala, Venture Partner, GV Vineeta is a physician-scientist who is passionate about the intersection of data science and health care. As a director of product management at Flatiron Health, she has led development of national-scale databases that integrate clinical and genomic data for drug development and research in oncology. Previously, Vineeta studied the genetic basis of common disease at the Broad Institute of Harvard & MIT. She has also been a computational researcher at Cold Spring Harbor Laboratory and Lawrence Livermore National Laboratory, an early data scientist at Boston-based health tech startup Kyruus, and a management consultant for biotech, pharmaceutical, and medical device clients at McKinsey & Company in New York. Vineeta has a B.S. in biophysics from Stanford University. She also earned M.D. and Ph.D. degrees from Harvard Medical School and MIT.

current job

Andreessen Horowitz
Andreessen Horowitz
RTW Investments LLC

RTW Investments LLC

RTW Investments is an innovative health care investment firm.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Financial Services, Health Care

Location

New York, NY, USA

count Of Investments

90

count Of Exists

3
GV

GV

GV is a venture capital firm that provides funding to innovative startups in various fields.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Mountain View, CA, USA

count Of Investments

820

count Of Exists

169
Brendan Bulik-Sullivan

Brendan Bulik-Sullivan

Brendan Bulik-Sullivan is a partner at GV where he focuses on life sciences investments. Prior to GV, Brendan’s career focused on applied statistics and machine learning research in genetics and biotechnology. He designed machine learning models for personalized immuno-oncology therapeutics at Gritstone Oncology and developed methods for statistical genetics research at the Broad Institute. Brendan’s work has been published in high-profile journals including Nature, Science, Nature Biotechnology and Nature Genetics.

current job

GV
GV

Activity

Recent News
1